ArticlePloS one2026
Association between obesity and neurodevelopmental delay risk in children under five years: A study from Tumbes, Peru.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundChildhood obesity is an emerging public health concern in low- and middle-income countries and may be associated with early neurodevelopmental vulnerability. Evidence on this association during early childhood remains limited, particularly in Latin American settings.
objectiveTo evaluate the association between childhood obesity and neurodevelopmental delay risk in children under five years of age attending public healthcare facilities in Tumbes, Peru, and to develop a multivariable nomogram for probabilistic risk estimation.
methodsAn analytical cross-sectional study was conducted between 2022 and 2024 among children aged 0-59 months receiving care at two EsSalud healthcare facilities in Tumbes. Neurodevelopment was assessed using the Evaluación del Desarrollo Infantil (EDI), classifying children as having normal development, developmental lag, or being at risk of developmental delay. Childhood obesity was defined using WHO weight-for-height standards. Sociodemographic, clinical, and behavioral variables were collected. Associations were evaluated using proportional odds ordinal logistic regression guided by a directed acyclic graph. A nomogram was developed based on the final model and internally validated using bootstrap resampling (1,000 iterations).
resultsThe final analytical sample included 431 children; 27% were classified as obese and 19% had anemia. According to the EDI, 58% had normal development, 36% developmental lag, and 6% were at risk of developmental delay. Childhood obesity was independently associated with higher cumulative odds of neurodevelopmental delay risk (OR = 2.73; 95% CI: 1.66-4.51). Male sex and older age group were also associated with increased risk, while higher caregiver knowledge of complementary feeding showed a protective association. Physical activity compliance and anemia were not independently associated in the multivariable model. The nomogram demonstrated acceptable internal discrimination (AUC > 0.7).
conclusionsChildhood obesity was associated with increased neurodevelopmental delay risk in children under five years of age. An explanation-informed nomogram using routinely available variables may support early risk stratification in primary care, although external validation is required before broader implementation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.